BioMed Research International

Novel Developments in Acute Kidney Injury


Status
Published

1Geisel School of Medicine at Dartmouth, Lebanon, USA

2Baylor Heart and Vascular Institute, Dallas, USA

3Vanderbilt University, Nashville, USA


Novel Developments in Acute Kidney Injury

Description

Acute kidney injury (AKI) develops routinely among hospitalized patients, perioperatively, as well as in the community. Although recent clinical trials have made great strides towards understanding the pathophysiology of acute kidney injury and therapeutic agents, effective prevention and treatment of acute kidney injury remain uncertain at the front lines of healthcare.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the pathophysiology, early detection, treatment, and prevention of acute kidney injury. We are particularly interested in novel meta-analyses of acute kidney injury treatment, prevention, and detection; advances in novel acute kidney injury pathophysiology; and new insights into acute kidney injury and clinical outcomes.

Potential topics include but are not limited to the following:

  • Meta-analyses
  • Advances in early detection and biomarkers
  • Latest technologies for prevention and treatment
  • Clinical evaluation of modifiable risk factors and devices to prevent or minimize acute kidney injury
  • Epidemiological studies
  • Community-acquired acute kidney injury
  • Recent advances in acute kidney injury prevention

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 2756204
  • - Editorial

Novel Developments in Acute Kidney Injury

Jeremiah R. Brown | Peter A. McCullough | Michael E. Matheny
  • Special Issue
  • - Volume 2016
  • - Article ID 4278579
  • - Review Article

Hospital Mortality in the United States following Acute Kidney Injury

Jeremiah R. Brown | Michael E. Rezaee | ... | Michael E. Matheny
  • Special Issue
  • - Volume 2016
  • - Article ID 5985903
  • - Research Article

Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model

Elerson C. Costalonga | Filipe M. O. Silva | Irene L. Noronha
  • Special Issue
  • - Volume 2016
  • - Article ID 4634386
  • - Research Article

Inhibitor of DNA Binding 1 Is Induced during Kidney Ischemia-Reperfusion and Is Critical for the Induction of Hypoxia-Inducible Factor-1α

Dan Wen | Yan-Fang Zou | ... | Wen Zhang
  • Special Issue
  • - Volume 2016
  • - Article ID 2015251
  • - Research Article

Clinical Characteristics and 30-Day Outcomes of Intermittent Hemodialysis for Acute Kidney Injury in an African Intensive Care Unit

Arthur Kwizera | Janat Tumukunde | ... | Robert Kalyesubula
  • Special Issue
  • - Volume 2016
  • - Article ID 7497936
  • - Research Article

Rhabdomyolysis following Cardiac Surgery: A Prospective, Descriptive, Single-Center Study

Amr S. Omar | Hesham Ewila | ... | Rajvir Singh
  • Special Issue
  • - Volume 2016
  • - Article ID 3019410
  • - Research Article

Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease

Sheila Marques Fernandes | Daniel Malisani Martins | ... | Maria de Fátima Fernandes Vattimo
  • Special Issue
  • - Volume 2016
  • - Article ID 2027370
  • - Review Article

Functional Magnetic Resonance Imaging in Acute Kidney Injury: Present Status

Hai Ying Zhou | Tian Wu Chen | Xiao Ming Zhang
  • Special Issue
  • - Volume 2016
  • - Article ID 8580475
  • - Research Article

Renal Ischemia/Reperfusion Injury in Diabetic Rats: The Role of Local Ischemic Preconditioning

Sule Ozbilgin | Sevda Ozkardesler | ... | Reci Meseri
  • Special Issue
  • - Volume 2016
  • - Article ID 4048390
  • - Review Article

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

Gi-Su Oh | Hyung-Jin Kim | ... | Hong-Seob So
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.